Literature DB >> 30536309

MiR-144-3p inhibits the proliferation and metastasis of pediatric Wilms' tumor cells by regulating Girdin.

C-L Liu1, W-H Wang, Y-L Sun, H-W Zhuang, M Xu, H-F Chen, J-X Liu.   

Abstract

OBJECTIVE: The aim of this study was to investigate the role of miR-144-3p in the proliferation and metastasis capacity of pediatric Wilms' tumor (WT) cells and to explore the underlying mechanism. PATIENTS AND METHODS: The quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was performed to measure the expression level of miR-144-3p in pediatric WT tissues and cell lines (G401). A bioinformatics software was utilized to predict the interaction between miR-144-3p and Girdin. Subsequently, the interaction was further verified by dual luciferase reporter (DLR) gene assay and Western blot. The proliferation and colony formation ability of G401 cells were examined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and colony formation assay, respectively. Finally, the effect of miR-144-3p on cell invasion and migration was analyzed by transwell assay.
RESULTS: In the current study, we found that the expression level of miR-144-3p was significantly reduced in pediatric WT tissues and cells, whereas Girdin expression was upregulated. On-line target gene prediction software was applied to screen Girdin, which was considered as a downstream target gene of miR-144-3p. The interaction between miR-144-3p and Girdin was further verified by dual Luciferase reporter gene assay and Western blot. Subsequent experiments demonstrated that the proliferation and metastasis ability of cells was remarkably suppressed after up-regulating the expression of miR-144-3p. However, an addition of Girdin could reverse the effect of miR-144-3p.
CONCLUSIONS: MiR-144-3p, which was up-regulated in pediatric WT, might inhibit the proliferation and metastasis of the cells by directly targeting Girdin. This further indicated that miR-144-3p could be a potential therapeutic target for the treatment of pediatric WT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30536309     DOI: 10.26355/eurrev_201811_16384

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Exposure to Heptachlorodibenzo-p-dioxin (HpCDD) Regulates microRNA Expression in Human Lung Fibroblasts.

Authors:  Collynn F Woeller; Thomas H Thatcher; Juilee Thakar; Adam Cornwell; Matthew R Smith; Dean P Jones; Philip K Hopke; Patricia J Sime; Pamela Krahl; Timothy M Mallon; Richard P Phipps; Mark J Utell
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

2.  Differential expression of miRNA in histological subtype of Wilms tumor.

Authors:  Disha Kakkar; Saumyaranjan Mallick; Aijaz Ahmad; Ansh Goswami; Sandeep Agarwala; Aditya Kumar Gupta; V Sreenivas; Sameer Bakhshi; K Devasenathipathy; Sandeep Mathur; Deepali Jain; Rachana Seth; Venkateswaran K Iyer
Journal:  Pediatr Surg Int       Date:  2021-10-21       Impact factor: 1.827

3.  Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR-144-3p and upregulating LPCAT1 in oral squamous cell carcinoma.

Authors:  Zhijian Su; Chao Pan; Honghui Xie; Yanyang Ning; Shuangjiang Li; Haibo Xiao
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-11

4.  Effects of miR-21 on proliferation and apoptosis of WT cells via PTEN/Akt pathway.

Authors:  Xiuli Zhang; Chunyan Liu; Haiyan Li; Li Guo
Journal:  Exp Ther Med       Date:  2019-12-27       Impact factor: 2.447

5.  LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression.

Authors:  Xingqin Zhou; Yazhou Chang; Lirong Zhu; Chaoyan Shen; Jing Qian; Renan Chang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis.

Authors:  Congjing An; Zhigang Hu; Yuehong Li; Pengxin Zhao; Runtian Liu; Qing Zhang; Peiling Zhu; Yanting Li; Ying Wang
Journal:  Cancer Cell Int       Date:  2022-05-12       Impact factor: 6.429

7.  Long non-coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA-143-3p/c-MET axis.

Authors:  Yu Tianhua; Li Dianqiu; Zhang Xuanhe; Zhang Zhe; Gao Dongmei
Journal:  J Cell Mol Med       Date:  2020-03-21       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.